12 Best Medical Stocks to Buy Now
On September 26, Geoff Meacham, Managing Director of Citi Research, appeared on CNBC’s “Closing Bell Overtime” to talk about President Trump’s plan to impose a 100% tariff on “all any branded...
Gilead Sciences Inc. (GILD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 5,666,392 | $628,232,881 | +4% | 0.84% |
| 2. | Citadel Investment Group Ken Griffin | 5,470,545 | $606,519,324 | +2% | 0.11% |
| 3. | Holocene Advisors Brandon Haley | 4,226,971 | $468,644,275 | +84% | 1.14% |
| 4. | AQR Capital Management Cliff Asness | 2,470,838 | $272,212,219 | +33% | 0.23% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,950,813 | $216,286,637 | +153% | 0.24% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.92 | 10,000 | $999,150.00 | 88,173 | 2015-02-06 | Filing | |
| $43.05 | 10,000 | $430,493.00 | 69,458 | 2013-02-28 | Filing | |
| $44.00 | 10,000 | $439,955.00 | 26,097 | 2012-02-22 | Filing | |
| $38.60 | 8,704 | $335,974.40 | 12,800 | 2010-05-04 | Filing | |
| $38.59 | 4,096 | $158,064.64 | 4,096 | 2010-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $112.42 | 1,961 | $220,454.25 | 591,203 | 2025-09-29 | Filing | |
| $111.47 | 8,039 | $896,109.74 | 593,164 | 2025-09-29 | Filing | |
| $113.57 | 3,000 | $340,710.00 | 113,193 | 2025-09-15 | Filing | |
| $113.57 | 2,500 | $283,925.00 | 159,555 | 2025-09-15 | Filing | |
| $113.63 | 10,000 | $1,136,300.00 | 595,725 | 2025-08-28 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 61,605 | $6,838,155 | 0.58% | |
| 2. | 37,171 | $4,125,981 | 0.71% | |
| 3. | 32,871 | $3,648,762 | 0.72% | |
| 4. | 981 | $108,854 | 0.1% | |
| 5. | 34,790 | $3,862 | 0.23% |
News See All
What Do Analysts Think About Gilead Sciences (GILD)?
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best large cap value stocks to buy now. On September 22, Morgan Stanley analyst Terence Flynn maintained a Buy rating on Gilead Sciences, Inc.
11 Best Large Cap Value Stocks to Buy Now
On September 26, Jeremy Siegel, Wharton professor emeritus and WisdomTree senior economist, appeared on CNBC's ‘Closing Bell’ to talk about the latest PCE report, whether the Fed should deemphasize...
Gilead Sciences (GILD) Stock Sees Positive Outlook Amid HIV, Liver, and Cancer Drug Momentum
Gilead Sciences, Inc. (NASDAQ:GILD) ranks among the most undervalued NASDAQ stocks to buy now. Citing momentum in Gilead Sciences, Inc.
11 Most Undervalued Growth Stocks to Buy According to Hedge Funds
On September 25, Stephen Parker, JPMorgan Private Bank's co-head of global investment strategy, joined CNBC for an interview to discuss the driving factors of the market.
JPMorgan Lifts Gilead Sciences, Inc. (GILD)'s Price Target To $145, Maintains Overweight Rating
Gilead Sciences, Inc. (NASDAQ:GILD) is among the Renaissance Technologies Portfolio: 10 Biggest Stocks.
14 Most Undervalued NASDAQ Stocks to Buy Now
On September 22, stocks surged to mark a third consecutive day of record-high closes, driven by hopes that the AI trade and additional Fed policy easing would boost the upward trend.
Why Gilead Sciences (GILD) Deserves Attention in the Cheap Quarterly Dividend Stocks Category
Gilead Sciences, Inc. (NASDAQ:GILD) is a California-based biopharmaceutical company that offers a wide range of products and services to its consumers.
11 Cheap Quarterly Dividend Stocks to Buy Right Now
Dividend investing is a strategy popular with both beginners and experienced investors, centered on creating steady income through regular dividend payments.
Renaissance Technologies Portfolio: 10 Biggest Stocks
The American quant hedge fund is known for using statistical and mathematical tools to drive its investment programs.